• No results found

[PDF] Top 20 Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a

Has 10000 "Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a" found on our website. Below are the top 20 most common "Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a".

Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a

Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a

... The factors that are associated with aggressive disease in PTC are age, male gender, large primary tumor size, and PTC variant histologic type such as tall cell, colum- nar cell, Hurthle cell, diffuse sclerosis, ... See full document

9

Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection

Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection

... for clinically LN negative PTC pa- tients; however, it is not acceptable performing prophy- lactic lateral LN dissection for PTC patients without clinical N1b ...were clinically N1b [8]. Few studies ... See full document

9

Total thyroidectomy without prophylactic central neck dissection in clinically node negative papillary thyroid cancer: is it an adequate treatment?

Total thyroidectomy without prophylactic central neck dissection in clinically node negative papillary thyroid cancer: is it an adequate treatment?

... lymph node dissection in the management of papillary thyroid cancer remains ...for clinically node-negative papillary thyroid ...pathological factors are ... See full document

8

Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node negative papillary thyroid cancer patients

Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node negative papillary thyroid cancer patients

... small papillary cancers (<1 cm) and a more precocious diagnosis are reported in clinical series requiring a less aggressive multimodal treatment [18, ...lymph node involvement of central and lateral ... See full document

5

EXTENT OF LATERAL NECK DISSECTION FOR DIFFERENTIATED THYROID CANCER: THE CONTROVERSY THEN AND NOW

EXTENT OF LATERAL NECK DISSECTION FOR DIFFERENTIATED THYROID CANCER: THE CONTROVERSY THEN AND NOW

... and clinically node-negative lateral ...lymph node metastasis were independently predictive of ...lymph node biopsy can help identify patients at risk for recurrence and ... See full document

9

Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis

Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis

... patients. Pathologic results were superimposed on the same ...a node-by-node com- parison in these 15 patients (a total of 60 nodal ...the node with the largest minimum diameter in 25 (93%) of ... See full document

5

Solitary lateral neck node metastasis in papillary thyroid carcinoma

Solitary lateral neck node metastasis in papillary thyroid carcinoma

... lymph node metastasis to determine the exact extent of neck dis- ...the risk of SLNM and decrease the extent of LND, without increasing lateral neck ... See full document

5

RRS1 gene expression involved in the progression of papillary thyroid carcinoma

RRS1 gene expression involved in the progression of papillary thyroid carcinoma

... galectin-3, thyroid peroxidase and keratin 19 are all widely used in diagnosis of PTC for adults ...American Thyroid Asso- ciation (ATA) Management guidelines for children points out that BRAF mutations are ... See full document

12

Original Article MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells

Original Article MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells

... Abstract: MicroRNAs (miRNAs) are kind of small non-coding RNAs that negatively regulate gene expression at post- transcription level, and those non-coding RNAs appear to play a key role in tumorigenesis. The aim of this ... See full document

12

Original Article Risk predictors for central lymph node metastasis and recurrence in CN0 papillary thyroid microcarcinoma

Original Article Risk predictors for central lymph node metastasis and recurrence in CN0 papillary thyroid microcarcinoma

... regional recurrence in the central ...pathological factors associated with CLNM to guide treatment ...the risk factors of central lymph node dissection (CLND) for CN0 patients, but the ... See full document

9

Original Article The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study

Original Article The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study

... the risk of LLNM in PTMC has not been well studied yet, one study demonstrated that PTMC patients with ETE ...a risk factor for LLNM, suggesting that males require careful examination of the thyroid ... See full document

9

Original Article Ultrasound features suspicious for malignancy predict the risk of BRAF mutation in papillary thyroid carcinoma

Original Article Ultrasound features suspicious for malignancy predict the risk of BRAF mutation in papillary thyroid carcinoma

... including microcalcifications, irregular borders, hypoechogenicity, and more height than width [17]. The ability to predict the BRAF mutation status using US characteristics would be very valuable for clinicians, as it ... See full document

6

Pin1 is related with clinical stage of papillary thyroid carcinoma

Pin1 is related with clinical stage of papillary thyroid carcinoma

... According to the 2014 NCCN Guidelines, 72 pa- tients were divided into four groups on the basis of their clinical data: 47 patients (65.28 %) had stage I disease, 3 (4.12 %) had stage II disease, 16 (22.22 %) had stage ... See full document

6

Original Article Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma

Original Article Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma

... lary thyroid microcarcinoma (PTMC) has been increased ...lymph node metastasis (CLNM) of PTMC was reported in ...locoregional recurrence and distant metastasis [3, 4]. The role of central lymph ... See full document

7

Expression of activator protein 1 in papillary thyroid carcinoma and its clinical significance

Expression of activator protein 1 in papillary thyroid carcinoma and its clinical significance

... Three-micrometer-thick, formalin-fixed sections were pre- pared and deparaffinized, and gradient alcohol hydration, endogenous peroxidase activity was blocked with 3% hydro- gen peroxide for 15 min. Antigen retrieval was ... See full document

5

Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma: a single-institution study, systemic review and meta-analysis

Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma: a single-institution study, systemic review and meta-analysis

... for thyroid cancer, N1a refers to metastatic dis- ease in the central compartment and N1b refers to metastasis to the lateral nodal ...American Thyroid Association guidelines [26] do not recommend ... See full document

9

Value of BRAF V600E in High Risk Thyroid Nodules with Benign Cytology Results

Value of BRAF V600E in High Risk Thyroid Nodules with Benign Cytology Results

... were papillary thyroid microcarcinomas (Fig ...with thyroid nodules with benign cytology results and negative for the BRAF V600E mutation, 27 were men and 229 were ...of thyroid nodules ... See full document

6

Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis

Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis

... transcription factors, such as ATF2, ATF3, ATF4, ATF7, DDIT3, and ...transcription factors and can cause abnormal transcriptional regulations of target genes which is related to leukemia development ...tion ... See full document

7

Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China

Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China

... and factors associated with PTC in People’s Republic of China and other countries, but the population living at moderate altitudes (1,500–2,500 m) on the Yunnan-Kweichow plateau in southwestern China has not been ... See full document

10

Young age increases the risk of lymph node positivity in papillary thyroid cancer patients: a SEER data-based study

Young age increases the risk of lymph node positivity in papillary thyroid cancer patients: a SEER data-based study

... Patients diagnosed with PTC were identified using histopathology codes of the International Classification of Diseases for Oncology, 3rd edition: 8050, 8260–8263, 8340–8344, 8450. Pathologically staged patients who ... See full document

7

Show all 10000 documents...